The Bio Report

563 Episodes

1. Bringing Gender Diversity into Biotech Boardrooms

   Published: 9/28/2017
2. Why the FDA May Need to Rethink Its Approach to Gene and Cell Therapy

   Published: 9/21/2017
3. VBL Targets Brain and other Cancers with Novel Immunotherapy

   Published: 9/14/2017
4. What Will It Take to Transform Healthcare to a System Focused on Prediction and Prevention

   Published: 9/7/2017
5. Can a Direct Pitch to Patients Drive a Home Run for Obesity Drug

   Published: 8/31/2017
6. Why Companies Across Industries Need to Develop a Bio Strategy

   Published: 8/24/2017
7. Economist Argues Maximizing Shareholder Value Hurts Drug Innovation

   Published: 8/17/2017
8. Partnership Drives Development of Antibiotic to Combat Resistant Gonorrhea

   Published: 8/10/2017
9. CIRM-Funded Pipeline of Regenerative Therapies Advances

   Published: 8/3/2017
10. Technology Allows Drugmakers to Tag and Authenticate Individual Pills

    Published: 7/27/2017
11. Harnessing Mosquitoes to Fight the Spread of Infectious Disease

    Published: 7/20/2017
12. Biotech Industry Moves Towards a Patent Cliff

    Published: 7/13/2017
13. PvP Takes a Unique Approach to Treating an Autoimmune Disease

    Published: 7/6/2017
14. Uncertainty Hangs over the Biotech Sector

    Published: 6/29/2017
15. What Others Can Learn from COI’s Approach to Cost-Efficient Drug Development

    Published: 6/22/2017
16. Dyadic Seek to Bring Disruptive Technology to Biomanufacturing

    Published: 6/15/2017
17. Enlisting the Immune System in the Battle Against Alzheimer’s

    Published: 6/8/2017
18. Overcoming the Delivery Challenges of Gene Therapy

    Published: 6/1/2017
19. Brexit Sparks Battle to House the EMA

    Published: 5/25/2017
20. New Safety Concerns Identified After FDA Approval of One in Three Drugs

    Published: 5/18/2017